We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+22.77%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$7.42B
AUM Growth
+$927M
Cap. Flow
+$49.5M
Cap. Flow %
0.67%
Top 10 Hldgs %
14.12%
Holding
1,799
New
559
Increased
265
Reduced
280
Closed
507

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$90.4M
2
CYTK icon
Cytokinetics
CYTK
+$14.7M
3
CI icon
Cigna
CI
+$13.5M
4
MPC icon
Marathon Petroleum
MPC
+$9.87M
5
CHTR icon
Charter Communications
CHTR
+$9.58M

Top Sells

Rank Stock Value
1
LMT icon
Lockheed Martin
LMT
+$28.8M
2
IP icon
International Paper
IP
+$25.9M
3
BMY icon
Bristol-Myers Squibb
BMY
+$18.8M
4
AMT icon
American Tower
AMT
+$16.2M
5
ONON icon
On Holding
ONON
+$14.9M

Sector Composition

Rank Sector Weight
1 Healthcare 2.67%
2 Communication Services 2.38%
3 Financials 1.61%
4 Technology 1.29%
5 Consumer Discretionary 1.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XPOF icon
951
Xponential Fitness
XPOF
$273M
$527K 0.01%
+40,893
New +$554K
NVCR icon
952
CALL
NovoCure
NVCR
$1.73B
$523K 0.01%
35,000
ELAN icon
953
PUT
Elanco Animal Health
ELAN
$13.2B
$522K 0.01%
35,000
+5,000
+17% +$56.6K
PAYO icon
954
CALL
Payoneer
PAYO
$2.42B
$521K 0.01%
100,000
TNDM icon
955
Tandem Diabetes Care
TNDM
$1.34B
$520K 0.01%
+17,584
New +$365K
DIS icon
956
Walt Disney
DIS
$167B
$520K 0.01%
+5,756
New +$507K
BCC icon
957
Boise Cascade
BCC
$2.69B
$517K 0.01%
+4,000
New +$429K
MPT
958
PUT
Medical Properties Trust
MPT
$2.77B
$516K 0.01%
+105,000
New +$514K
EDIT icon
959
CALL
Editas Medicine
EDIT
$396M
$515K 0.01%
+50,800
New +$446K
LAC
960
Lithium Americas
LAC
$1.01B
$513K 0.01%
+80,114
New +$596K
GLUE icon
961
Monte Rosa Therapeutics
GLUE
$1.4B
$512K 0.01%
+90,690
New +$356K
PD icon
962
PagerDuty
PD
$816M
$509K 0.01%
+22,000
New +$476K
LAR
963
Lithium Argentina AG
LAR
$985M
$507K 0.01%
+80,266
New +$484K
PACB icon
964
Pacific Biosciences
PACB
$435M
$507K 0.01%
51,673
-91,275
-64% -$746K
PFE icon
965
Pfizer
PFE
$143B
$501K 0.01%
+17,400
New +$526K
ABUS icon
966
CALL
Arbutus Biopharma
ABUS
$857M
$500K 0.01%
200,000
ABUS icon
967
PUT
Arbutus Biopharma
ABUS
$857M
$500K 0.01%
200,000
PDD icon
968
Pinduoduo
PDD
$126B
$498K 0.01%
3,404
-18,596
-85% -$2.26M
CLSK icon
969
CleanSpark
CLSK
$3.53B
$496K 0.01%
+45,000
New +$280K
NTGR icon
970
NETGEAR
NTGR
$648M
$495K 0.01%
33,917
+26,217
+340% +$339K
EVLV icon
971
Evolv Technologies
EVLV
$995M
$491K 0.01%
103,939
-54,293
-34% -$232K
WULF icon
972
CALL
TeraWulf
WULF
$8.75B
$491K 0.01%
204,400
-414,100
-67% -$564K
PGTI
973
DELISTED
PGT, Inc.
PGTI
$488K 0.01%
+12,000
New +$390K
YUMC icon
974
Yum China
YUMC
$16.5B
$488K 0.01%
+11,500
New +$535K
CORT icon
975
CALL
Corcept Therapeutics
CORT
$12.4B
$487K 0.01%
15,000
-15,000
-50% -$412K

Similar funds

Caption Management's Q4 2023 Portfolio in Review

As of Q4 2023, Caption Management held 1,799 positions worth $7.42B, up 14% from $6.49B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Caption Management's Q4 2023 filing shows 559 new, 265 increased, 280 reduced and 507 closed positions. Its largest new stake was Verizon: 2,556,000 shares worth $96.4M. The largest sale was Lockheed Martin, an estimated $28.8M.

By sector, the portfolio is most concentrated in Healthcare at 2.7% of assets, up from 2.4% a quarter earlier, followed by Communication Services and Financials.

  • Caption Management's largest Q4 2023 buy was Verizon: 2,556,000 shares worth $96.4M.
  • Caption Management added most to Cytokinetics in Q4 2023, an estimated $14.7M increase.
  • Caption Management's biggest Q4 2023 reduction was International Paper, cutting an estimated $25.9M.
  • Caption Management fully exited Lockheed Martin in Q4 2023, selling an estimated $28.8M.
  • Caption Management's ten largest holdings make up 14% of its $7.42B portfolio in Q4 2023.
  • Caption Management opened 559 new positions and closed 507 in Q4 2023.
  • Caption Management's portfolio value rose 14% quarter-over-quarter to $7.42B.

Based on Caption Management's 13F filing for Q4 2023, filed 14 Feb 2024.